Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

Adjustments to Financial Statements

Microsoft Excel

Adjustments to Current Assets

CVS Health Corp., adjusted current assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Current assets 67,858 65,682 60,008 56,369 50,302
Adjustments
Add: Allowance for credit losses 343 333 339 358 319
After Adjustment
Adjusted current assets 68,201 66,015 60,347 56,727 50,621

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Adjustments to Total Assets

CVS Health Corp., adjusted total assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Total assets 249,728 228,275 232,999 230,715 222,449
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowance for credit losses 343 333 339 358 319
Less: Deferred income tax assets2 131
After Adjustment
Adjusted total assets 250,071 228,477 233,338 231,073 222,768

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred income tax assets. See details »


Adjustments to Total Liabilities

CVS Health Corp., adjusted total liabilities

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Total liabilities 173,092 156,960 157,618 161,014 158,279
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred income tax liabilities2 4,311 3,880 6,270 6,794 7,294
Less: Restructuring charge liability 150
After Adjustment
Adjusted total liabilities 168,631 153,080 151,348 154,220 150,985

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred income tax liabilities. See details »


Adjustments to Stockholders’ Equity

CVS Health Corp., adjusted total CVS Health shareholders’ equity

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Total CVS Health shareholders’ equity 76,461 71,015 75,075 69,389 63,864
Adjustments
Less: Net deferred income tax assets (liabilities)1 (4,311) (3,749) (6,270) (6,794) (7,294)
Add: Allowance for credit losses 343 333 339 358 319
Add: Restructuring charge liability 150
Add: Noncontrolling interests 175 300 306 312 306
After Adjustment
Adjusted total shareholders’ equity 81,440 75,397 81,990 76,853 71,783

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Net deferred income tax assets (liabilities). See details »


Adjustments to Capitalization Table

CVS Health Corp., adjusted capitalization table

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Short-term debt 200
Current portion of long-term debt 2,772 1,778 4,205 5,440 3,781
Long-term debt, excluding current portion 58,638 50,476 51,971 59,207 64,699
Total reported debt 61,610 52,254 56,176 64,647 68,480
Total CVS Health shareholders’ equity 76,461 71,015 75,075 69,389 63,864
Total reported capital 138,071 123,269 131,251 134,036 132,344
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Current portion of operating lease liabilities2 1,741 1,678 1,646 1,638 1,596
Add: Long-term operating lease liabilities3 16,034 16,800 18,177 18,757 18,926
Adjusted total debt 79,385 70,732 75,999 85,042 89,002
Adjustments to Equity
Less: Net deferred income tax assets (liabilities)4 (4,311) (3,749) (6,270) (6,794) (7,294)
Add: Allowance for credit losses 343 333 339 358 319
Add: Restructuring charge liability 150
Add: Noncontrolling interests 175 300 306 312 306
Adjusted total shareholders’ equity 81,440 75,397 81,990 76,853 71,783
After Adjustment
Adjusted total capital 160,825 146,129 157,989 161,895 160,785

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Current portion of operating lease liabilities. See details »

3 Long-term operating lease liabilities. See details »

4 Net deferred income tax assets (liabilities). See details »


Adjustments to Reported Income

CVS Health Corp., adjusted net income attributable to CVS Health

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Net income attributable to CVS Health 8,344 4,149 7,910 7,179 6,634
Adjustments
Add: Deferred income tax expense (benefit)1 (676) (2,075) (428) (564) (649)
Add: Increase (decrease) in allowance for credit losses 10 (6) (19) 39 32
Add: Increase (decrease) in restructuring charge liability 150
Less: Loss from discontinued operations, net of tax (9)
Add: Other comprehensive income (loss), net of tax 967 (2,430) (449) 395 917
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest 24 16 (12) 13 (3)
After Adjustment
Adjusted net income 8,819 (346) 7,002 7,071 6,931

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Deferred income tax expense (benefit). See details »